GATA2 mutation
|
AML
|
GATA2 mutation
|
AML
|
gilteritinib Resistant: B - Late Trials
|
gilteritinib Resistant: B - Late Trials
|
GATA2 mutation
|
AML
|
GATA2 mutation
|
AML
|
LY3009120 Resistant: C3 – Early Trials
|
LY3009120 Resistant: C3 – Early Trials
|